Abboud, Camille N.
Lang, Nicole
Fung, Henry
Lammerich, Andreas
Buchner, Anton
Liu, Patrick
Mueller, Udo
Pettengell, Ruth
Diel, Ingo J.
Link, Hartmut
Pathak, Ashutosh
Article History
Received: 29 January 2018
Accepted: 19 October 2018
First Online: 15 November 2018
Compliance with ethical standards
: Camille Abboud reports research funding from Merck, Teva, Novartis, Pfizer, and Seattle Genetics (clinical trial support); and consulting for Gerson and Lehman Group, Agios, Jazz Pharma, Pfizer, and Cardinal Health. Anton Buchner reports employment of Teva ratiopharm, and reports equity ownership in Teva Branded Pharmaceutical Products R&D, Inc. Andreas Lammerich reports employment and equity ownership in Teva ratiopharm/Teva Pharmaceuticals, Inc. Nicole Lang reports employment with Teva ratiopharm/Teva Pharmaceuticals, Inc. Hartmut Link reports research funding from Amgen and Hexal and honoraria from Teva. Patrick Liu reports employment with Teva Pharmaceuticals, Inc. Udo W. Mueller reports employment and equity ownership with Teva Pharmaceuticals, Inc. Ashutosh Pathak reports employment with Teva Pharmaceuticals, Inc. Henry Fung reports receiving honoraria from Amgen and Teva. Ruth Pettengell reports honoraria from CTI, Servier, Teva, Roche, Takeda and Pfizer.
Free to read: This content has been made available to all.